Biotech Belonged to the Bears in Second Half of 2021

A bearish sentiment in biotechnology took over in the second half of 2021, providing gains for the Direxion Daily S&P Biotech Bear 3X Shares (LABD). LABD climbed almost 21% in the second half of 2021, giving bearish biotech traders something to cheer about. Of course, it helps to have leverage...